Terms: = Endocrine gland cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Treatment
41 results:
1. HERC4 modulates ovarian cancer cell proliferation by regulating smo-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract] [Full Text] [Related]
2. Elucidating the Role of miRNA-326 Modulating Hedgehog Signaling in Pancreatic Carcinoma.
Rashid S; Rashid S; Das P; Malik N; Dash NR; Singh N; Pandey RM; Kumar L; Chauhan SS; Chosdol K; Gupta S; Saraya A
Pancreas; 2024 Jan; 53(1):e42-e48. PubMed ID: 38019614
[TBL] [Abstract] [Full Text] [Related]
3. The value of second opinions on thyroid nodule management provided via direct-to-consumer telemedicine service.
Benaim E; Dudley S; Grande P; Gillespie MB
Am J Otolaryngol; 2023; 44(2):103732. PubMed ID: 36682146
[TBL] [Abstract] [Full Text] [Related]
4. [Effects of a novel spermine oxidase inhibitor SI-4650 on proliferation and EMT of human ovarian cancer SKVO-3 cells].
Yang JL; Tian JJ; Zhang H; Chen QY; Lyu YF; Cao CY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Mar; 38(2):175-180. PubMed ID: 36031578
[No Abstract] [Full Text] [Related]
5. Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma.
Saddozai UAK; Wang F; Akbar MU; Zhang L; An Y; Zhu W; Xie L; Li Y; Ji X; Guo X
Front Endocrinol (Lausanne); 2021; 12():605797. PubMed ID: 34234737
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
[No Abstract] [Full Text] [Related]
7. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Martinez NL; Khanna O; Farrell CJ
Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
[TBL] [Abstract] [Full Text] [Related]
8. Surgeon-performed ultrasound-guided fine needle aspiration of thyroid nodules is cost effective and efficient: evaluation of thyroid nodule assessment in a provincial New Zealand hospital.
Reeves M; Patel R; Harmston C
N Z Med J; 2019 Nov; 132(1506):60-65. PubMed ID: 31778373
[TBL] [Abstract] [Full Text] [Related]
9. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
[TBL] [Abstract] [Full Text] [Related]
10. Tumor Priming by smo Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model.
Wang J; Chan DKW; Sen A; Ma WW; Straubinger RM
Mol Cancer Ther; 2019 Nov; 18(11):2074-2084. PubMed ID: 31363010
[TBL] [Abstract] [Full Text] [Related]
11. The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer.
Jia Y; Gu D; Wan J; Yu B; Zhang X; Chiorean EG; Wang Y; Xie J
Oncogene; 2019 Mar; 38(10):1764-1777. PubMed ID: 30382189
[TBL] [Abstract] [Full Text] [Related]
12. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway.
Song L; Chen X; Wang P; Gao S; Qu C; Liu L
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):586-596. PubMed ID: 29697746
[TBL] [Abstract] [Full Text] [Related]
13. Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy.
Sherman WH; Hecht E; Leung D; Chu K
Oncologist; 2018 Jan; 23(1):4-e10. PubMed ID: 29212734
[TBL] [Abstract] [Full Text] [Related]
14. GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment.
Zhou Q; Zhou Y; Liu X; Shen Y
Sci Rep; 2017 Oct; 7(1):13379. PubMed ID: 29042665
[TBL] [Abstract] [Full Text] [Related]
15. Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas.
Ozretić P; Trnski D; Musani V; Maurac I; Kalafatić D; Orešković S; Levanat S; Sabol M
Int J Oncol; 2017 Dec; 51(6):1869-1877. PubMed ID: 29039491
[TBL] [Abstract] [Full Text] [Related]
16. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic cancer.
Kumar V; Chaudhary AK; Dong Y; Zhong HA; Mondal G; Lin F; Kumar V; Mahato RI
Sci Rep; 2017 May; 7(1):1665. PubMed ID: 28490735
[TBL] [Abstract] [Full Text] [Related]
17. Malignancy risk of oncocytic changes in thyroid nodules: who should we offer surgery to?
Yazici P; Yilmaz B; Bozkurt E; Mihmanli M; Uludag M
Acta Chir Belg; 2016 Feb; 116(1):30-5. PubMed ID: 27385138
[TBL] [Abstract] [Full Text] [Related]
18. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
[TBL] [Abstract] [Full Text] [Related]
19. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
20. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract] [Full Text] [Related]
[Next]
